Navigation Links
Diplomat Specialty Pharmacy Expands National Hemophilia & IVIG Program

SWARTZ CREEK, Mich., Feb. 4 /PRNewswire/ -- Diplomat Specialty Pharmacy is pleased to announce two new "Navigator" initiatives (disease management programs). As of January 2009, DSP launched both a Hemophilia and IVIG Navigator Program. In addition, Scott Reed has joined Diplomat as National Sales Manager for both programs. Reed is a graduate of Indiana University and has over 18 years of pharmaceutical sales experience. Most recently Reed was a Hematology Account Executive with Bayer HealthCare, prior to that he was a Sales Manager with ZLB (CSL Behring). Reed will report directly to Mark Neville, Vice President of Sales and Marketing.

Reed will team with Diplomat's Director of Pharmacy Development and Operations, Rinku A. Patel, RPh, PharmD. Patel will lead the development of program infrastructure to support Diplomat's Hemophilia and IVIG Navigator programs.

"Hemophilia patients require a very high touch patient care model and Diplomat's services are a perfect fit for these patients," stated Patel. "Diplomat's Navigator Programs, through direct patient care and coordination with providers, improve access, tolerance, and compliance resulting in enhanced clinical and economic outcomes for patients with bleeding disorders."

"Diplomat Specialty Pharmacy is very excited to welcome Scott to our team," said Neville. "Under Dr. Patel's clinical expertise, Scott will lead our efforts in launching Diplomat's national program that will provide the highest level of clinical care to patients with bleeding disorders and IVIG needs."

"After spending many years in the hemophilia marketplace, I am happy to join the team at Diplomat Specialty Pharmacy," said Reed. "A hemophilia and IVIG program can improve medication adherence, control costs and improve quality of life. Diplomat's Disease Management programs are the most comprehensive and innovative programs available. I look forward to being a part of the great things that are happening at Diplomat Specialty Pharmacy."

About Diplomat Specialty Pharmacy

Diplomat Specialty Pharmacy is the nation's largest independently held Specialty Pharmacy and focuses on complete medication management programs for patients with serious and chronic conditions. Key programs include: Oncology, HIV/AIDS, Hepatitis C, Multiple Sclerosis, Rheumatoid Arthritis, Crohn's and Psoriasis. Other specialty areas include Transplant, Fertility, Dialysis Medication Management, Bio-Identical Hormone Replacement Therapy and Specialty Compounding. The company also specializes in Disease Management programs for Chronic Kidney Disease patients, as well as Home and Out-Patient Infusion. With locations in Flint, Swartz Creek and Grand Rapids, MI; Cleveland, OH; Chicago, IL; and Ft. Lauderdale, Florida; Diplomat services the specialty pharmacy needs of patients and physicians nationwide.

    For more information contact:
    Kathy Karns

SOURCE Diplomat Specialty Pharmacy
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Diplomat Specialty Pharmacy Health Services Division Achieves High Marks in Pilot Program for Chronic Kidney Disease Management
2. Diplomat Specialty Pharmacy Hires Vice President of Managed Markets
3. Diplomat Specialty Pharmacy Hires National Accounts Manager to Expand Multiple Sclerosis Program
4. Diplomat Specialty Pharmacy Sponsors National Managed Care Roundtable for Industry Executive Advisory Board
5. Diplomats 2008 Patient Satisfaction Survey Sets the Bar for Specialty Pharmacy Industry
6. Diplomat Specialty Pharmacy Hires Rinku A. Patel, PharmD as Director of Pharmacy Development and Operations
7. Patient Treatment for Bipolar Disorder Varies Depending on Doctor Specialty; Well Designed Clinical Trials May Be The Answer
8. Baxter Adds Recombinant Protein to Specialty Therapeutics Portfolio
9. Botaneco signs feasibility agreement with Croda to develop specialty crop oil formulation
10. West Pharmaceutical Services to Present at the 2008 UBS Global Specialty & Generic Pharmaceuticals Conference
11. Atrium completes the sale of its Active Ingredients and Specialty Chemicals division
Post Your Comments:
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader ... “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, ... providing practical tips, tools, and strategies for clinical researchers. , “The landscape of ...
(Date:6/23/2016)... TORONTO , June 23, 2016 /PRNewswire/ - ... Ontario biotechnology company, Propellon ... the development and commercialization of a portfolio of ... cancers. Epigenetic targets such as WDR5 represent an ... contribute significantly in precision medicine for cancer patients. ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. ... test has received AOAC Research Institute approval 061601. , “This is another AOAC-RI ... stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate ...
(Date:6/23/2016)... June 23, 2016   EpiBiome , a precision ... million in debt financing from Silicon Valley Bank (SVB). ... and to advance its drug development efforts, as well ... "SVB has been an incredible strategic partner ... a traditional bank would provide," said Dr. Aeron ...
Breaking Biology Technology:
(Date:6/15/2016)... ALBANY, New York , June 15, 2016 ... published a new market report titled "Gesture Recognition Market ... Trends and Forecast, 2016 - 2024". According to the ... at USD 11.60 billion in 2015 and is ... and reach USD 48.56 billion by 2024.  ...
(Date:6/3/2016)... 3, 2016 Das ... Nepal hat ein 44 ... geprägter Kennzeichen, einschließlich Personalisierung, Registrierung und IT-Infrastruktur, ... Produktion und Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte ... Januar teilgenommen, aber Decatur wurde als konformste ...
(Date:6/1/2016)... NEW YORK , June 1, 2016 ... Biometric Technology in Election Administration and Criminal Identification to ... According to a recently released TechSci Research report, " ... Sector, By Region, Competition Forecast and Opportunities, 2011 - ... $ 24.8 billion by 2021, on account of growing ...
Breaking Biology News(10 mins):